Ranibizumab versus dexamethasone implant for central retinal vein occlusion: special remarks of the RANIDEX study
Citation:
Chatziralli I, Theodossiadis G, Kabanarou SA, Theodossiadis P. Ranibizumab versus dexamethasone implant for central retinal vein occlusion: special remarks of the RANIDEX study. Graefe's Archive for Clinical and Experimental Ophthalmology. 2017;255:2077–2078.
National and Kapodistrian University of Athens 2nd Department of Ophthalmology, Attikon Hospital 1, Rimini street, Haidari, 12462 Tel: (+30) 210-5831337 Email: eirchat@med.uoa.gr; eirchat@yahoo.gr